Olmesartan Decreased Levels of IL-1β and TNF-α, Down-Regulated MMP-2, MMP-9, COX-2, RANK/RANKL and Up-Regulated SOCs-1 in an Intestinal Mucositis Model

Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: An exploratory study of the Gynecologic Oncology Group

(2014) Krishnansu S. Tewari et al.   GYNECOLOGIC ONCOLOGY

A preclinical study on the protective effect of melatonin against methotrexate-induced small intestinal damage: effect mediated by attenuation of nitrosative stress, protein tyrosine nitration, and PARP activation

(2013) Viswa Kalyan Kolli et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis

(2013) Di Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model

(2013) Aurigena A. Araújo et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis

(2013) Aurigena Antunes Araújo et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

IL-10 Inhibits the NF-κB and ERK/MAPK-Mediated Production of Pro-Inflammatory Mediators by Up-Regulation of SOCS-3 in Trypanosoma cruzi-Infected Cardiomyocytes

(2013) Eugenia Hovsepian et al.   PLoS One

Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats

(2012) Rowaida Refaat et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Risk factors for refractory febrile neutropenia in urological chemotherapy

(2012) Tomihiko Yasufuku et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat

(2011) Noor Al-Dasooqi et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases

(2010) Minoru Fujimoto et al.   Gastroenterology Research and Practice

Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress

(2009) Mustafa Gulgun et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γ

(2009) Ayuko Nakano et al.   HYPERTENSION RESEARCH

RANK-RANKL Signaling Pathway Is Critically Involved in the Function of CD4 + CD25 + Regulatory T Cells in Chronic Colitis

(2009) Teruji Totsuka et al.   JOURNAL OF IMMUNOLOGY

Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake

(2008) Nabile Boukhettala et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM